The leadership team has professional experience in healthcare, sales and marketing, technology, venture financing, pharmaceutical marketing, and e-Detailing that enables Altient to rapidly deploy a product line while maintaining leadership advantage with new technology and innovative service strategies.

• Jim Gossett Founder, President and Chief Executive Officer, possesses an in-depth understanding of technology and the back-end business of physician practices, having worked as Director of Physician Client Services with iPhysicianNet, a leading pharmaceutical e-Detailing company, as well as previously founding another company that went on to have a successful IPO in 1996.

• Daryll Bennett Founder & Chief Technology Officer, was previously the Senior Network Engineer and MIS Manager at Venture Catalyst, a publicly traded Southern California based web hosting and design facility.

• Michelle Muradoglu Director of Physician Relations & Development, responsible for physician recruitment and retention, was previously Manager of Physician Sales for iPhysicianNet, a leading pharmaceutical e-Detailing company, where she was responsible for recruiting national contracts representing some 19,000 physicians.





• James C. Crews retired on May 1, 2000 as President and Chief Executive Officer of Banner Health Arizona, a division of the Banner Health System formed in September 1999 as a result of a merger between Samaritan Health System and Lutheran Health Systems. Mr. Crews has spent over 36 years as the Chief Executive Officer of hospitals and integrated health systems in the United States.

• Rob Dhoble EVP, Director Global Healthcare Operations Diversified Agency Services/Omnicom Group. Rob Dhoble is charged with integrating and coordinating the efforts of the firm's healthcare agencies, specialized healthcare marketing services companies and Omnicom general advertising agencies on a worldwide platform to successfully support the needs of global brand initiatives. In conjunction with his corporate responsibility for client-centric strategy development, Rob's efforts seek to capitalize on the increasing desire of clients to select strong agency teams that can execute complete communications solutions across multiple audiences on a worldwide basis. In coordination with DAS/Omnicom firms, his client strategies include the customization of brand-building solutions that span the full scope of the pharmaceutical and biotechnology research and development process.
Rob was previously President of Acuity HealthGroup, a healthcare relationship-marketing consultancy within Rapp Collins Worldwide. Before joining Omnicom in 1998, Rob was COO of Torre Lazur Healthcare Group, a unit of McCann-Erickson Worldwide. Prior to enjoying the variety and complexity of the service side, Rob has held successive marketing and sales management positions within Lederle Laboratories, Wallace Laboratories, and Rorer Pharmaceuticals. His industry perspective has been featured in Pharmaceutical Executive, The Economist, Product Management Today, American Demographics and Medical Marketing & Media.
The Diversified Agencies Services (DAS) unit of Omnicom Group represents the world's most comprehensive healthcare communications practice. DAS supports its clients' emerging brand needs through a unique brand communications continuum that ranges from preclinical testing and global naming to regulatory submission and post-patent commercialization. The DAS Global Healthcare practice is a dedicated resource within the firm, supported by the Director of Global Healthcare Operations. Integrated business solutions comprise an ever-increasing share of its client work, supported by the Global Lifecycle Solutions(SM) process and capabilities.

• Jo Fendly has over 22 years of Pharmaceutical industry experience, specifically in providing sales and marketing information solutions to leading pharmaceutical companies. Most recently Ms. Fendly was the National Sales Director for NDC Health, Inc. With 18 years at Walsh/PMSI (now NDC Health), Jo was instrumental in developing physician and managed care targeting tools, call reporting systems, and sales compensation reporting for sales force management. Jo also has extensive experience in developing integrated data warehouse systems with the largest pharmaceutical manufacturers.

• Gregg A. Fiddes has held a variety of senior-level positions in the wireless technology, Internet transaction and handheld computing industries. Most recently, Mr. Fiddes was Vice-President of Palm's Enterprise Business Group in charge of Palm's Enterprise Strategy, Product Development, Product Marketing and Business Development. Mr. Fiddes was instrumental in developing Palm's first corporate wireless email product and partnership deals with Wireless Carriers, Siebel, ThinAir Apps, Extended Systems and others. Prior to Palm, Mr. Fiddes was the North America Group Manager for Business Development for VeriFone/Hewlett-Packard's Internet Commerce Division. Mr. Fiddes worked at BellSouth International and BellSouth Mobile Data where he developed cellular and wireless data businesses domestically and internationally. Mr. Fiddes started his career in GE's Technical Marketing Program and was a leading sales representative in GE's Electrical Distribution and Programmable Controls Division. Mr. Fiddes holds a BSME from Worcester Polytechnic Institute and an MBA from Babson Graduate School of Business.

• Karl Fledderjohn is the former President of AlliedSignal, Equipment and Controls Group, previously AiResearch Group, where he was responsible for 9 divisions with $1.6 billion in sales. Mr. Fledderjohn has a B.S. in Mechanical Engineering from Kettering University, and an MBA from Butler University.

• Joseph Gossett MD, is a former physician. Dr. Gossett was the Medical Director of Scottsdale Health Care System's Out-Patient Surgery Department for 25 years, and President of Scottsdale Billing Service (a medical billing corporation) for 20 years. Dr. Gossett has a Medical Degree from the University of Iowa.

• James A. Miller CPA, is a prior Partner of PriceWaterhouse LLP (now PriceWaterhouse Coopers). Mr. Miller was based in the Chicago office, but also served in the Sydney-Australia, Karachi-Pakistan, New York-USA, and London-England (including the Middle East and Africa) offices. His experience includes working on acquisitions and mergers and audit and advisory services in the healthcare, communications, food, and manufacturing sectors, among others. Mr. Miller has a B.B.A. from the University of Iowa.

• Daniel Sullivan, is president and CEO of Sinus Rhythm Technologies, a Company developing a technology to deal with cardiac abnormalities known as atrial fibrillation. Formerly, Mr. Sullivan was President and CEO of Vascular Science, founded in 1996 to develop products and procedures to do coronary bypass surgery without using sutures. The company had raised over $10 million privately to finance its growth and was sold to St. Jude Medical in September 1999 for $80 million plus future consideration. Previously, he was one of the key executives that built SCIMED, which was sold to Boston Scientific Corporation for over $800 million. His board positions include: Atritech, Inc. C0-founder and Member of the Board. Incisive Surgical, Inc. Member of the Board. NeuroVasx, Inc. Member of the Board.